The Journal of Organic Chemistry
Note
1634, 1603, 1506, 1437, 1327, 1263, 1152, 1101, 817, 751, 693 cm−1;
HRMS (ESI) calcd for C11H14NO2, 192.1025, found 192.1019.
3-Methylene-4-(phenylamino)pentan-2-one (1e). 32 mg, 69%
ASSOCIATED CONTENT
■
S
* Supporting Information
General information and copies of 1H, 13C NMR spectra for all
products. This material is available free of charge via the
1
yield: Yellow Gum; H NMR (400 MHz, CDCl3) δ 1.34 (d, 3H, J =
6.8 Hz), 2.37 (s, 3H), 3.93 (brs, 1H), 4.47 (q, 1H, J = 6.4 Hz), 5.97 (s,
1H), 6.05 (s, 1H), 6.47 (d, 2H, J = 8.0 Hz), 6.67 (t, 1H, J = 7.2 Hz),
7.12 (t, 2H, J = 7.6 Hz); 13C NMR (100 MHz, CDCl3) δ 22.2, 26.7,
48.9, 113.3, 117.5, 125.0, 129.1, 146.6, 150.3, 199.9.; IR (KBr) 3389,
3051, 3020, 2925, 2857, 1663, 1602, 1504, 1389, 1281, 1131, 750, 693
cm−1; HRMS (ESI) calcd for C12H16NO, 190.1232, found 190.1227.
2-Methylene-3-(phenylamino)pentanal (1f). 25 mg, 54% yield:
Colorless gum;1H NMR (400 MHz, CDCl3) δ 0.96 (t, 3H, J = 8.0
Hz), 1.63 (m, 1H), 1.78 (m, 1H), 3.94 (s, 1H), 4.20 (t, 1H, J = 6.4
Hz), 6.04 (s, 1H), 6.35 (s, 1H), 6.47 (d, 2H, J = 7.2 Hz), 6.66 (t, 1H, J
= 7.2 Hz), 7.11 (t, 2H, J = 8.4 Hz), 9.61 (s, 1H); 13C NMR (100 MHz,
CDCl3) δ 10.9, 28.3, 53.9, 113.5, 117.8, 129.4, 135.4, 147.0, 150.4,
194.6; IR (KBr) 3392, 3022, 2965, 2931, 2873, 1683, 1599, 1504,
1315, 1259, 1031, 751, 693 cm−1; HRMS (ESI) calcd for C12H16NO,
190.1232, found 190.1223.
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We are grateful to the Louisiana Board of Regents for financial
support.
REFERENCES
■
(1) For recent reviews on aza-MBH reaction, see: (a) Declerck, V.;
Martinez, J.; Lamaty, F. Chem. Rev. 2009, 109, 1. (b) Shi, Y.-L.; Shi, M.
Eur. J. Org. Chem. 2007, 2905. (c) Masson, G.; Housseman, C.; Zhu, J.
Angew. Chem., Int. Ed. 2007, 46, 4614. (d) Basavaiah, D.; Rao, K. V.;
Reddy, R. J. Chem. Soc. Rev. 2007, 36, 1581.
(2) (a) Basavaiah, D.; Rao, A. J.; Satyanarayana, T. Chem. Rev. 2003,
103, 811. (b) Sorbetti, J. M.; Clary, K. N.; Rankic, D. A.; Wulff, J. E.;
Parvez, M.; Back, T. G. J. Org. Chem. 2007, 72, 3326. (c) Nemoto, T.;
Fukuyama, T.; Yamamoto, E.; Tamura, S.; Fukuda, T.; Matsumoto, T.;
Akimoto, Y.; Hamada, Y. Org. Lett. 2007, 9, 927. (d) Basavaiah, D.;
Rao, P. D.; Hyma, R. S. Tetrahedron 1996, 52, 8001. (e) Singh, V.;
Batra, S. Tetrahedron 2008, 64, 4511.
2-Methylene-3-(phenylamino)butanal (1g). 27 mg, 61% yield:
1
Colorless gum; H NMR (400 MHz, CDCl3) δ 1.40 (d, 3H, J = 6.8
Hz), 3.92 (brs, 1H), 4.40 (q, 1H, J = 6.8 Hz), 6.03 (s, 1H), 6.39 (s,
1H), 6.48 (d, 2H, J = 8.0 Hz), 6.69 (t, 1H, J = 7.6 Hz), 7.13 (t, 2H, J =
8.0 Hz), 9.65 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 21.8, 47.9,
113.5, 117.9, 129.4, 134.5, 146.6, 151.7, 194.6; IR (KBr) 33399, 2964,
2893, 1684, 1601, 1504, 1317, 1261, 1027, 799, 751, 693 cm−1; HRMS
(ESI) calcd for C11H14NO, 176.1075, found 176.1062.
2-Methylene-3-(phenylamino)butanenitrile (1i). 18 mg, 42%
yield: Brownish gum; 1H NMR (400 MHz, CDCl3) δ 1.50 (t, 3H, J =
3.6 Hz), 3.80 (d, 1H, J = 4.8 Hz), 4.10 (m, 1H), 5.94 (s, 1H), 5.95 (s,
1H), 6.55 (d, 2H, J = 7.6 Hz), 6.76 (t, 1H, J = 7.6 Hz), 7.18 (t, 2H, J =
8.0 Hz); 13C NMR (100 MHz, CDCl3) δ 21.3, 52.4, 113.7, 117.6,
118.7, 126.6, 129.5, 129.8, 145.7; IR (KBr) 3392, 3052, 2972, 2905,
2221, 1602, 1505, 1315, 1259, 1157, 1029, 945, 750 cm−1; HRMS
(ESI) calcd for C11H13N2, 173.1079, found 173.1067.
Ethyl 3-(p-Tolylamino)-2-methylenebutanoate (2a). 41 mg,
72% yield: Colorless gum; 1H NMR (400 MHz, CDCl3) δ 1.32 (t, 3H,
J = 7.2 Hz), 1.40 (d, 3H, J = 6.8 Hz), 2.22 (s, 3H), 4.24 (q, 2H, J = 7.2
Hz), 4.36 (q, 1H, J = 6.4 Hz), 5.73 (s, 1H), 6.16 (s, 1H), 6.46 (d, 2H, J
= 7.2 Hz), 6.95 (d, 2H, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3) δ
14.4, 20.6, 22.2, 50.7, 60.9, 113.8, 124.5, 126.9, 129.8, 142.6, 144.6,
166.8.; IR (KBr) 3401, 2978, 2893, 1709, 1617, 1519, 1373, 1284,
1182, 1105, 808 cm−1; HRMS (ESI) calcd for C14H19NO2 (M + H+)
234.1494, found 234.1486.
(3) (a) Pozza, M. F.; Zimmermann, K.; Bischoff, S.; Lingenhohl, K.
̈
Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2000, 24, 647. (b) Zhi,
L.; Tegley, C. M.; Marschke, K. B.; Jones, T. K. Bioorg. Med. Chem.
Lett. 1999, 9, 1009. (c) Scarborough, R. M.; Gretler, D. D. J. Med.
Chem. 2000, 43, 3453. (d) Mousa, S. A. Drug Discovery Today 1999, 4,
552.
(4) (a) Shi, M.; Chen, L.-H.; Li, C.-Q. J. Am. Chem. Soc. 2005, 127,
3790. (b) Raheem, I. T.; Jacobsen, E. N. Adv. Synth. Catal. 2005, 347,
1701.
(5) Yu, C.; Liu, B.; Hu, L. J. Org. Chem. 2001, 66, 5413.
(6) (a) Bertenshaw, S.; Kahn, M. Tetrahedron Lett. 1989, 30, 2731.
(b) Aggarwal, V. K.; Castro, A. M. M.; Mereu, A.; Adams, H.
Tetrahedron Lett. 2002, 43, 1577.
(7) Sprung, M. A. Chem. Rev. 1940, 26, 297.
(8) (a) Balan, D.; Adolfsson, H. J. Org. Chem. 2001, 66, 6498.
(b) Balan, D.; Adolfsson, H. J. Org. Chem. 2002, 67, 2329.
(9) (a) Patra, A.; Roy, A. K.; Batra, S.; Bhaduri, A. P. Synlett 2002,
1819. (b) Kim, J. N.; Lee, H. J.; Lee, K. Y.; Gong, J. H. Synlett 2002,
173. (c) Park, D. Y.; Lee, M. J.; Kim, T. H.; Kim, J. N. Tetrahedron Lett.
2005, 46, 8799. (d) Krawczyk, E.; Owsianik, K.; Skowronska, A.
Tetrahedron 2005, 61, 1449.
(10) (a) Brown, J. M.; James, A. P.; Prior, L. M. Tetrahedron Lett.
1987, 28, 2179. (b) Kim, S. J.; Lee, H. S.; Kim, J. M.; Kim, J. N. Bull.
Korean Chem. Soc. 2008, 29, 265. (c) Chen, H.-Y.; Patkar, L. N.; Ueng,
S.-H.; Lin, C.-C.; Lee, A. S.-Y. Synlett 2005, 2035. (d) Sa, M. M.;
Ramos, M. D.; Fernandes, L. Tetrahedron 2006, 62, 11652.
(11) Adam, W.; Krebs, O. Chem. Rev. 2003, 103, 4131.
(12) (a) Srivastava, R. S.; Khan, M. A.; Nicholas, K. M. J. Am. Chem.
Soc. 1996, 118, 3311. (b) Srivastava, R. S.; Nicholas, K. M. J. Am.
Chem. Soc. 1997, 119, 3302. (c) Srivastava, R. S.; Khan, M. A.;
Nicholas, K. M. J. Am. Chem. Soc. 2005, 127, 7278. (d) Srivastava, R.
S.; Tarver, N. R.; Nicholas, K. M. J. Am. Chem. Soc. 2007, 129, 15250.
(e) Murru, S.; Gallo, A. A.; Srivastava, R. S. ACS Catal. 2011, 1, 29.
(f) Murru, S.; Gallo, A. A.; Srivastava, R. S. Eur. J. Org. Chem. 2011, 11,
2035.
Ethyl 3-(2-Bromophenylamino)-2-methylenebutanoate (3a).
1
58 mg, 78% yield: Brownish oil; H NMR (400 MHz, CDCl3) δ 1.33
(t, 3H, J = 6.8 Hz), 1.46 (d, 3H, J = 6.8 Hz), 4.25 (q, 2H, J = 6.8 Hz),
4.47 (t, 1H, J = 6.8 Hz), 4.58 (s, 1H), 5.70 (s, 1H), 6.19 (s, 1H), 6.45
(d, 1H, J = 8.0 Hz), 6.54 (t, 1H, J = 6.8 Hz), 7.10 (t, 1H, J = 7.2 Hz),
7.41 (d, 1H, J = 8.0 Hz); 13C NMR (100 MHz, CDCl3) δ 14.4, 22.2,
50.0, 61.0, 109.9, 112.7, 118.1, 124.4, 128.5, 132.5, 142.1, 143.5, 166.6;
IR (KBr) 3411, 3068, 2979, 2933, 1713, 1595, 1505, 1459, 1321, 1282,
1128, 1105, 1019, 954, 815, 742 cm−1; HRMS (ESI) calcd for
C13H17BrNO2 (M + H+), 298.0443, 300.0422, found 298.0436,
300.0418.
Ethyl 3-(2-Iodophenylamino)-2-methylenebutanoate (4a).
69 mg, 81% yield: Brownish oil; 1H NMR (400 MHz, CDCl3) δ
1.26 (t, 3H, J = 7.2 Hz), 1.40 (d, 3H, J = 6.0 Hz), 4.20 (q, 2H, J = 7.2
Hz), 4.36 (brs, 2H), 5.62 (s, 1H), 6.12 (s, 1H), 6.30−6.37 (m, 2H),
7.06 (t, 1H, J = 6.8 Hz), 7.58 (d, 1H, J = 8.0 Hz); 13C NMR (100
MHz, CDCl3) δ 13.2, 21.0, 49.1, 59.8, 84.4, 110.8, 117.8, 123.3, 128.3,
138.0, 141.0, 144.6, 165.4; IR (KBr) 3392, 3064, 2970, 2927, 1716,
1589, 1506, 1449, 1270, 1124, 1102, 1005, 742 cm−1; HRMS (ESI)
calcd for C13H17INO2, 346.0304, found 346.0307.
(13) (a) Johannsen, M.; Jorgensen, K. A. J. Org. Chem. 1994, 59, 214.
(b) Singh, S.; Nicholas, K. M. Syn. Commun. 2001, 31, 3087.
D
dx.doi.org/10.1021/jo301266f | J. Org. Chem. XXXX, XXX, XXX−XXX